Avicenna Introduces Machine Learning-Enhanced Medicinal Chemistry Platform to Accelerate the Last Mile of Small Molecule Drug Discovery
Avicenna Biosciences today introduced an extension to its machine learning (ML) technology platform to enhance medicinal chemistry and expedite clinical-stage drug discovery.
- Avicenna Biosciences today introduced an extension to its machine learning (ML) technology platform to enhance medicinal chemistry and expedite clinical-stage drug discovery.
- “Avicenna is applying novel ML methods to navigate the unknowns in medicinal chemistry and design around them.
- Our methods allow a drug design team to learn from years of failure and optimize against validated targets more efficiently.
- For more information on Avicenna and its technology platform or to inquire about partnership opportunities, visit www.avicenna-bio.com .